Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

French Multicentre Observational Study of a Prospective Cohort of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

NCT02147938 is registered in ClinicalTrials.gov with Astellas Pharma S.A.S. as lead sponsor.

NCT NCT02147938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02147938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
French Multicentre Observational Study of a Prospective Cohort of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
Lead sponsor
Astellas Pharma S.A.S.
Phase
Observational
Overall status
Completed
Start date
July 17, 2014
Completion date
May 15, 2017
Enrollment
578 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation